organoid screening - HUB Organoids

10 years of breakthroughs in Organoid Technology: from adult stem cell discovery to changing patients’ lives

September 13, 2023

10 years of breakthroughs in Organoid Technology: from adult stem cell discovery to changing patients’ lives

Dr. Robert Vries, CEO

Patient-derived organoids: an emerging platform to de-risk immunotherapy development

May 19, 2023

Patient-derived organoids: an emerging platform to de-risk immunotherapy development

Dr. Sylvia F. Boj, Chief Scientific Officer

Recent advancements in patient-derived organoid technology and their impact on drug development

April 3, 2023

Recent advancements in patient-derived organoid technology and their impact on drug development

Dr. Sylvia F. Boj, Chief Scientific Officer

Patient in the lab®: downscaling patient-derived organoid screening

February 17, 2022

Patient in the lab®: downscaling patient-derived organoid screening

René Overmeer, Head of Assay Development and Automation HUB Organoids

Model human disease and identify predictive biomarkers of response

February 17, 2022

Model human disease and identify predictive biomarkers of response

Robert Vries, CEO HUB Organoids

Understanding mechanism of disease and identifying therapeutic interventions with HUB Organoids

February 17, 2022

Understanding mechanism of disease and identifying therapeutic interventions with HUB Organoids

Robert Vries, CEO HUB Organoids